Invizyne Technologies Stock (NASDAQ:IZTC)
Previous Close
$15.50
52W Range
$8.50 - $23.99
50D Avg
$15.57
200D Avg
$14.78
Market Cap
$157.23M
Avg Vol (3M)
$37.03K
Beta
-4.51
Div Yield
-
IZTC Company Profile
Invizyne Technologies Inc. is an American synthetic biochemical company that has developed SimplePath, an innovative platform. This technology is designed to synthesize a diverse range of chemicals, including vital substances like pharmaceuticals, fuels, and advanced materials, as well as food additives and entirely novel compounds. At its core, SimplePath is composed of specialized modules, each integrating one or more enzymes that collaboratively execute defined biocatalytic conversions. Established in 2014, Invizyne Technologies' operations are headquartered in Monrovia, California.